How Logilab ELN Builds Audit Confidence for Pharmaceutical Companies, Every Step of the Way

How Logilab ELN Builds Audit Confidence for Pharmaceutical Companies, Every Step of the Way

A pharmaceutical company involved in manufacturing active pharmaceutical ingredients (APIs), advanced intermediates, etc., faced growing challenges in maintaining data integrity and meeting 21 CFR Part 11 Compliance requirements. Manual documentation, legacy systems, and complex validation processes slowed laboratory operations and increased compliance risk. This case study outlines how adopting Logilab ELN enabled the organization to modernize laboratory workflows and strengthen regulatory compliance without disrupting ongoing operations.

Inside this case study, you’ll learn:

• How Logilab ELN helps support data integrity, security, and full traceability of laboratory records
• How electronic signatures, audit trails, and role-based access controls simplified FDA 21 CFR Part 11 compliance
• How digitized, structured lab workflows reduced paper-based processes, improved sample management, and laboratory efficiency